ARCN1 and glioma: Further logistic regression analyses revealed that patients with the rs7115634 G allele in the ARCN1 gene had a 21% reduction of glioma risk (adjusted OR = 0.79, 95%CI = 0.70–0.89, P = 2.12×10−4).